Skip to main content
Clinical Trials/NCT04230993
NCT04230993
Completed
Not Applicable

Clinical Evaluation of the Efficacy of Two Nasal Products for Decongestion and Mucus Fluidification

YSLab1 site in 1 country210 target enrollmentDecember 24, 2019
ConditionsRhinitis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Rhinitis
Sponsor
YSLab
Enrollment
210
Locations
1
Primary Endpoint
Effect of nasal washing with a hypertonic seawater solution Nose hygiene).
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The main objective is to compare the effect of nasal washing on nasal discharge and nasal congestion during treatment after 3 days of use.

Detailed Description

The main endpoint is a symptom score derived from the Jackson scale: sum of 2 items relating to runny nose and nasal congestion (stuffy nose), with ratings of 0 to 3 for each (0: absent ; 1: mild; 2: moderate; 3: severe).

Registry
clinicaltrials.gov
Start Date
December 24, 2019
End Date
June 20, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
YSLab
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Person with an upper respiratory condition (cold, rhinitis, nasopharyngitis ...) with symptoms of nasal congestion and intense runny nose moderate to severe (Jackson derived score ≥ 4)
  • Ability of the patient (for adults) or their legal representative (for children) to follow the guidelines of the medical device
  • have given their written informed consent

Exclusion Criteria

  • Patient with no cold symptoms, including no nasal congestion (chronic dry rhinitis...)
  • Patient under treatment with cortisone derivative, mucolytic, or medication containing pseudoephedrine or related product acting on nasal congestion or having used such a product in the 3 days before inclusion
  • Patient who used a nasal wash product in the 3 days before inclusion
  • Patient allergic to seafood, or to any of the components of the products under study
  • Vulnerable patient whose inclusion is not justified by the research objectives: woman pregnant, parturient, psychiatric patient, or adult subject to legal protection
  • Patient participating or having participated in any other clinical study in the 30 days before the study.

Outcomes

Primary Outcomes

Effect of nasal washing with a hypertonic seawater solution Nose hygiene).

Time Frame: 3 days

Effect of nasal washing with a hypertonic seawater solution (Ocean Bio Actif-Fluid + or Ocean Bio Actif-Stuffy nose) on runny nose and nasal congestion during treatment after 3 days of use, compared to an isotonic solution (Ocean Bio Actif- Nose hygiene). symptom score (runny nose and nasal congestion) derived from the Jackson scale with a score of 0 to 3 for each (0: absent; 1: mild; 2: moderate; 3: severe) between Day 0 and Day 3.

Secondary Outcomes

  • Likert scale(7 days)
  • Symptom score(7 days)
  • Number of concomitant treatment(7 days)
  • Safety of medical device(7 days)
  • Presence or absence of fluid mucus(7 days)
  • Global Clinical Impression Scale(between day 3 and day 7)
  • Global Patient Impression Scale(between day 3 and day 7)
  • Use of medical device(7 days)

Study Sites (1)

Loading locations...

Similar Trials